| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |